Clinical Trial Update: A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing IMP4297 as maintenance therapy after first-line chemotherapy in patients with advanced ovarian cancer; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• IMP4297 (IMP4297)

Snippet

Sponsor: Impact Therapeutics, Inc. | Conditions: Ovarian Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING